SSO 2020 - Society of Surgical Oncology's International Conference on Surgical Cancer Care (Virtual Meeting)
Aug 17 - Aug 18, 2020 | BostonMAUS
LARVOL is not affiliated with Society of Surgical Oncology's International Conference on Surgical Cancer Care (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 8 abstracts linked to Trials
[VIRTUAL] Neoadjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Resectable BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria: A Preliminary Report of a Phase III, Randomized, Controlled Clinical Trial
[VIRTUAL] Primary 2-year Results of Phase 2, Multicenter, Randomized, Open-label Trial of Efficacy and Safety for Talimogene Laherparepvec (T-VEC) Neoadjuvant Treatment Plus Surgery versus Surgery in Patients with Resectable Stage IIIBIVM1a Melanoma
[VIRTUAL] KEYNOTE-522 Study of Pembro + Chemo vs. Placebo + Chemo as Neoadjuvant Treatment Followed by Pembro vs. Placebo as Adjuvant Treatment for Early TNBC: Pathologic Complete Response in Key Subgroups
[VIRTUAL] Perioperative Arginine Immunonutrition Prevents Metastases by Accelerating Natural Killer Cell Recovery After Surgery
[VIRTUAL] SMAD4 Loss is Associated with Response to Neoadjuvant Chemotherapy with Hydroxychloroquine in Patients with Pancreatic Adenocarcinoma
[VIRTUAL] Adjuvant Nivolumab (NIVO) Versus Ipilimumab (IPI) in Resected Stage III/IV Melanoma: 3-Year Efficacy and Biomarker Results From the Phase 3 Checkmate 238 Trial
[VIRTUAL] Interim Results of Phase II trial for Novel Magnetic Resonance Imaging of Peritoneal Mesothelioma
[VIRTUAL] Combination Immunotherapy (IT) and Chemotherapy (CT) Can Improve Pathologic Complete Responses (pCR) in Women with Triple Negative (TNBC) and HER2+ Breast Cancer (BC) but Does Not Improve Predictability for Post Therapy Magnetic Resonance Imaging (MRI)